You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Ovarian Cancer

:

Citations 21-30 of 32 total displayed.

Past content (since Aug 1998):

Letters
Hormone Therapy and Risk of Gynecologic Cancers
Wulf H. Utian
JAMA 2004; 291: 42-a. [Extract] [Full text] [PDF]  

Letters
Hormone Therapy and Risk of Gynecologic Cancers—Reply
Garnet L. Anderson; Howard L. Judd; Andrew M. Kaunitz; S. Gene McNeeley; David H. Barad; James Liu; Ana Maria Lopez; Shirley A. A. Beresford; Mary Pettinger
JAMA 2004; 291: 43. [Extract] [Full text] [PDF]  

Letters
Sex Ratios in Families With BRCA Mutations—Reply
Miguel de la Hoya; Juan M Fernández; Alicia Tosar; Javier Godino; Ana Sánchez de Abajo; José A Vidart; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés
JAMA 2003; 290: 2544-b-2545-b. [Extract] [Full text] [PDF]  

Letters
Sex Ratios in Families With BRCA Mutations
Matthew E. Mealiffe
JAMA 2003; 290: 2544-a. [Extract] [Full text] [PDF]  

Original Contributions
Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures: The Women's Health Initiative Randomized Trial
Garnet L. Anderson; Howard L. Judd; Andrew M. Kaunitz; David H. Barad; Shirley A. A. Beresford; Mary Pettinger; James Liu; S. Gene McNeeley; Ana Maria Lopez
JAMA 2003; 290: 1739-1748. [Abstract] [Full text] [PDF]  

Brief Reports
Association Between BRCA1 Mutations and Ratio of Female to Male Births in Offspring of Families With Breast Cancer, Ovarian Cancer, or Both
Miguel de la Hoya; Juan M. Fernández; Alicia Tosar; Javier Godino; Ana Sánchez de Abajo; Jose A. Vidart; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés
JAMA 2003; 290: 929-931. [Abstract] [Full text] [PDF]  

Corrections
Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer
JAMA 2002; 288: 2544. [Full text] [PDF]  

Original Contributions
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Jae-Hoon Kim; Steven J. Skates; Toshimitsu Uede; Kwong-kwok Wong; John O. Schorge; Colleen M. Feltmate; Ross S. Berkowitz; Daniel W. Cramer; Samuel C. Mok
JAMA 2002; 287: 1671-1679. [Abstract] [Full text] [PDF]  

Original Contributions
Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
Carmen Rodriguez; Alpa V. Patel; Eugenia E. Calle; Eric J. Jacob; Michael J. Thun
JAMA 2001; 285: 1460-1465. [Abstract] [Full text] [PDF]  

Original Contributions
Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer
Jeff Boyd; Yukio Sonoda; Mark G. Federici; Faina Bogomolniy; Esther Rhei; Diane L. Maresco; Patricia E. Saigo; Lois A. Almadrones; Richard R. Barakat; Carol L. Brown; Dennis S. Chi; John P. Curtin; Elizabeth A. Poynor; William J. Hoskins
JAMA 2000; 283: 2260-2265. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4

 Collections
 •Sign up for Topic Collection Alerts
 • Show Ovarian Cancer
 collections from JAMA & Archives Journals.
 •Topic Collections Home
 •Related collections:
  •Oncology
  •Brain Cancer
  •Breast Cancer
  •Cervical Cancer
  •Colon Cancer
  •Head & Neck Cancer
  •Lung Cancer
  •Ovarian Cancer
  •Prostate Cancer
  •Skin Cancer
  •Oncology, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.